These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24105394)

  • 1. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy.
    Marzano AV; Borghi A; Stadnicki A; Crosti C; Cugno M
    Inflamm Bowel Dis; 2014 Jan; 20(1):213-27. PubMed ID: 24105394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
    Károlyi Z; Erós N; Ujszászy L; Nagy G
    Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy.
    Marzano AV; Borghi A; Meroni PL; Crosti C; Cugno M
    Autoimmunity; 2014 May; 47(3):146-53. PubMed ID: 24437626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
    Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
    Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
    Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: skin complications associated with inflammatory bowel disease.
    Tavarela Veloso F
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():50-3. PubMed ID: 15352894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous manifestations in inflammatory bowel disease].
    Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations in inflammatory bowel disease: a single institutional study of non-neoplastic biopsies over 13 years.
    Ko JS; Uberti G; Napekoski K; Patil DT; Billings SD
    J Cutan Pathol; 2016 Nov; 43(11):946-955. PubMed ID: 27494987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
    Apgar JT
    Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population.
    Jo UH; Lee JY; Lee H; Kim DY; Kang S; Koh SJ; Park H
    J Dermatol; 2021 Apr; 48(4):431-438. PubMed ID: 33608949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin manifestations of pediatric inflammatory bowel disease].
    Martín de Carpi J; Chávez Caraza K; Vicente Villa MA; González Enseñat MA; Vilar Escrigas P; Vila Miravet V; Guallarte Alias P; Varea Calderón V
    An Pediatr (Barc); 2009 Jun; 70(6):570-7. PubMed ID: 19446510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
    He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X
    Front Immunol; 2023; 14():1234535. PubMed ID: 37954590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study.
    Moravvej H; Razavi GM; Farshchian M; Malekzadeh R
    Indian J Dermatol Venereol Leprol; 2008; 74(6):607-10. PubMed ID: 19171983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases.
    Colìa R; Corrado A; Cantatore FP
    Ann Med; 2016 Dec; 48(8):577-585. PubMed ID: 27310096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin Manifestations of Inflammatory Bowel Disease.
    Greuter T; Navarini A; Vavricka SR
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):413-427. PubMed ID: 28643285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained Remission of Lupus Panniculitis Treated With Hydroxychloroquine in a Patient With Crohn's Disease: A Case Report.
    Zheng DD; Mantis J; Gurung DO; Abrudescu A
    Cureus; 2020 Sep; 12(9):e10455. PubMed ID: 33072463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.